Clinical Trial Update: Study of Magnitude and Prediction of Response to Omalizumab and Mepolizumab in Adult Severe Asthma. [Phase 4]

View source ↗

Summary

Phase 4 trial updates the magnitude and predictors of response to omalizumab and mepolizumab in adult severe asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Mepolizumab (mepolizumab)
• Omalizumab (Omalizumab)

Snippet

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Conditions: Severe Asthma | Phase 4 | Status: UNKNOWN